GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 5 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,969,000 | +7.8% | 1,574,979 | +0.0% | 0.00% | – |
| Q4 2021 | $1,827,000 | -39.1% | 1,574,879 | +0.8% | 0.00% | – |
| Q3 2021 | $3,001,000 | -16.6% | 1,563,101 | +1.6% | 0.00% | – |
| Q2 2021 | $3,600,000 | -17.8% | 1,538,463 | -4.9% | 0.00% | – |
| Q1 2021 | $4,382,000 | +12.4% | 1,617,044 | +0.4% | 0.00% | – |
| Q4 2020 | $3,898,000 | +5.2% | 1,610,826 | -0.5% | 0.00% | – |
| Q3 2020 | $3,707,000 | +105.6% | 1,618,686 | +106.5% | 0.00% | – |
| Q2 2020 | $1,803,000 | +35.9% | 783,968 | +1.6% | 0.00% | – |
| Q1 2020 | $1,327,000 | -17.0% | 771,422 | -0.1% | 0.00% | – |
| Q4 2019 | $1,598,000 | -28.6% | 771,922 | 0.0% | 0.00% | – |
| Q3 2019 | $2,238,000 | -24.0% | 771,922 | +2.7% | 0.00% | – |
| Q2 2019 | $2,946,000 | – | 751,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |